Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/Ranibizumab> ?p ?o }
- Ranibizumab abstract "Ranibizumab (trade name Lucentis among others) is a monoclonal antibody fragment (Fab) created from the same parent mouse antibody as bevacizumab. It is an anti-angiogenic that has been approved to treat the "wet" type of age-related macular degeneration (AMD, also ARMD), a common form of age-related vision loss.Its effectiveness is similar to that of bevacizumab. Its rates of side effects also appear similar. However, ranibizumab typically costs $2,000 a dose, while the equivalent dose of bevacizumab typically costs $50.Ranibizumab was developed by Genentech and is marketed in the United States by Genentech and elsewhere by Novartis, under the brand name Lucentis.".
- Ranibizumab atcPrefix "S01".
- Ranibizumab atcSuffix "LA04".
- Ranibizumab casNumber "347396-82-1".
- Ranibizumab drugbank "DB01270".
- Ranibizumab fdaUniiCode "ZL1R02VT79".
- Ranibizumab wikiPageExternalLink www.lucentis.com.
- Ranibizumab wikiPageID "6190706".
- Ranibizumab wikiPageLength "15198".
- Ranibizumab wikiPageOutDegree "29".
- Ranibizumab wikiPageRevisionID "679032349".
- Ranibizumab wikiPageWikiLink Age-related_wet_macular_degeneration.
- Ranibizumab wikiPageWikiLink Angiogenesis.
- Ranibizumab wikiPageWikiLink Angiogenesis_inhibitor.
- Ranibizumab wikiPageWikiLink Anti-angiogenics.
- Ranibizumab wikiPageWikiLink Bevacizumab.
- Ranibizumab wikiPageWikiLink Cataract.
- Ranibizumab wikiPageWikiLink Category:Monoclonal_antibodies.
- Ranibizumab wikiPageWikiLink Category:Ophthalmology_drugs.
- Ranibizumab wikiPageWikiLink Central_retinal_vein_occlusion.
- Ranibizumab wikiPageWikiLink Endophthalmitis.
- Ranibizumab wikiPageWikiLink Floater.
- Ranibizumab wikiPageWikiLink Fragment_antigen-binding.
- Ranibizumab wikiPageWikiLink Genentech.
- Ranibizumab wikiPageWikiLink Intraocular_pressure.
- Ranibizumab wikiPageWikiLink Intravitreal_administration.
- Ranibizumab wikiPageWikiLink Macular_degeneration.
- Ranibizumab wikiPageWikiLink Macular_edema.
- Ranibizumab wikiPageWikiLink Monoclonal_antibody.
- Ranibizumab wikiPageWikiLink New_England_Journal_of_Medicine.
- Ranibizumab wikiPageWikiLink Novartis.
- Ranibizumab wikiPageWikiLink Retinal_detachment.
- Ranibizumab wikiPageWikiLink The_New_England_Journal_of_Medicine.
- Ranibizumab wikiPageWikiLink The_New_York_Times.
- Ranibizumab wikiPageWikiLink Vascular_endothelial_growth_factor_A.
- Ranibizumab wikiPageWikiLink Vision_loss.
- Ranibizumab wikiPageWikiLink Visual_impairment.
- Ranibizumab wikiPageWikiLink Vitreous_humour.
- Ranibizumab wikiPageWikiLinkText "Lucentis".
- Ranibizumab wikiPageWikiLinkText "Ranibizumab".
- Ranibizumab wikiPageWikiLinkText "ranibizumab".
- Ranibizumab atcPrefix "S01".
- Ranibizumab atcSuffix "LA04".
- Ranibizumab c "2158".
- Ranibizumab casNumber "347396".
- Ranibizumab chembl "1201825".
- Ranibizumab chemspiderid "NA".
- Ranibizumab drugbank "DB01270".
- Ranibizumab eliminationHalfLife "777600.0".
- Ranibizumab h "3282".
- Ranibizumab hasPhotoCollection Ranibizumab.
- Ranibizumab kegg "D05697".
- Ranibizumab legalUk "POM".
- Ranibizumab legalUs "Rx-only".
- Ranibizumab licenceEu "Lucentis".
- Ranibizumab mabType "Fab".
- Ranibizumab medlineplus "a607044".
- Ranibizumab molecularWeight "48350".
- Ranibizumab n "562".
- Ranibizumab o "681".
- Ranibizumab pregnancyUs "C".
- Ranibizumab routesOfAdministration Intravitreal_administration.
- Ranibizumab s "12".
- Ranibizumab source "zu/o".
- Ranibizumab target Vascular_endothelial_growth_factor_A.
- Ranibizumab tradename "Lucentis".
- Ranibizumab type "mab".
- Ranibizumab unii "ZL1R02VT79".
- Ranibizumab verifiedfields "changed".
- Ranibizumab verifiedrevid "464380069".
- Ranibizumab watchedfields "changed".
- Ranibizumab wikiPageUsesTemplate Template:Drugbox.
- Ranibizumab wikiPageUsesTemplate Template:Monoclonals_for_bone,_musculoskeletal,_circulatory,_and_neurologic_systems.
- Ranibizumab wikiPageUsesTemplate Template:Ocular_vascular_disorder_agents.
- Ranibizumab wikiPageUsesTemplate Template:Official_website.
- Ranibizumab wikiPageUsesTemplate Template:Reflist.
- Ranibizumab subject Category:Monoclonal_antibodies.
- Ranibizumab subject Category:Ophthalmology_drugs.
- Ranibizumab hypernym Fragment.
- Ranibizumab type Article.
- Ranibizumab type ChemicalSubstance.
- Ranibizumab type Drug.
- Ranibizumab type Antibody.
- Ranibizumab type Article.
- Ranibizumab type Chemical.
- Ranibizumab type ChemicalObject.
- Ranibizumab type Thing.
- Ranibizumab type Q8386.
- Ranibizumab comment "Ranibizumab (trade name Lucentis among others) is a monoclonal antibody fragment (Fab) created from the same parent mouse antibody as bevacizumab. It is an anti-angiogenic that has been approved to treat the "wet" type of age-related macular degeneration (AMD, also ARMD), a common form of age-related vision loss.Its effectiveness is similar to that of bevacizumab. Its rates of side effects also appear similar.".
- Ranibizumab label "Ranibizumab".
- Ranibizumab sameAs Ranibizumab.
- Ranibizumab sameAs Ranibizumab.
- Ranibizumab sameAs Ranibizumab.
- Ranibizumab sameAs ラニビズマブ.
- Ranibizumab sameAs m.0fv_4x.
- Ranibizumab sameAs Ранибизумаб.
- Ranibizumab sameAs Ranibizumab.
- Ranibizumab sameAs Ranibizumab.
- Ranibizumab sameAs Q414270.
- Ranibizumab sameAs Q414270.